ENST00000615790.5:c.*2923T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000615790.5(PEG10):c.*2923T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.785 in 167,110 control chromosomes in the GnomAD database, including 52,226 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.78 ( 47514 hom., cov: 33)
Exomes 𝑓: 0.80 ( 4712 hom. )
Consequence
PEG10
ENST00000615790.5 3_prime_UTR
ENST00000615790.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.369
Publications
24 publications found
Genes affected
PEG10 (HGNC:14005): (paternally expressed 10) This is a paternally expressed imprinted gene that is thought to have been derived from the Ty3/Gypsy family of retrotransposons. It contains two overlapping open reading frames, RF1 and RF2, and expresses two proteins: a shorter, gag-like protein (with a CCHC-type zinc finger domain) from RF1; and a longer, gag/pol-like fusion protein (with an additional aspartic protease motif) from RF1/RF2 by -1 translational frameshifting (-1 FS). While -1 FS has been observed in RNA viruses and transposons in both prokaryotes and eukaryotes, this gene represents the first example of -1 FS in a eukaryotic cellular gene. This gene is highly conserved across mammalian species and retains the heptanucleotide (GGGAAAC) and pseudoknot elements required for -1 FS. It is expressed in adult and embryonic tissues (most notably in placenta) and reported to have a role in cell proliferation, differentiation and apoptosis. Overexpression of this gene has been associated with several malignancies, such as hepatocellular carcinoma and B-cell lymphocytic leukemia. Knockout mice lacking this gene showed early embryonic lethality with placental defects, indicating the importance of this gene in embryonic development. Additional isoforms resulting from alternatively spliced transcript variants, and use of upstream non-AUG (CUG) start codon have been reported for this gene. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.915 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PEG10 | NM_001172437.2 | c.*1775T>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_001165908.1 | |||
| PEG10 | NM_001184961.1 | c.*1775T>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_001171890.1 | |||
| PEG10 | NM_015068.3 | c.*1775T>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_055883.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PEG10 | ENST00000615790.5 | c.*2923T>C | 3_prime_UTR_variant | Exon 2 of 2 | 1 | ENSP00000482653.2 | ||||
| PEG10 | ENST00000482108.1 | c.*2923T>C | 3_prime_UTR_variant | Exon 2 of 2 | 1 | ENSP00000417587.1 | ||||
| PEG10 | ENST00000612941.2 | c.*1775T>C | 3_prime_UTR_variant | Exon 3 of 3 | 5 | ENSP00000478744.2 |
Frequencies
GnomAD3 genomes AF: 0.784 AC: 119228AN: 152116Hom.: 47462 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
119228
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.796 AC: 11837AN: 14876Hom.: 4712 Cov.: 0 AF XY: 0.792 AC XY: 5594AN XY: 7060 show subpopulations
GnomAD4 exome
AF:
AC:
11837
AN:
14876
Hom.:
Cov.:
0
AF XY:
AC XY:
5594
AN XY:
7060
show subpopulations
African (AFR)
AF:
AC:
4
AN:
4
American (AMR)
AF:
AC:
3
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
3
AN:
4
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
11697
AN:
14688
Middle Eastern (MID)
AF:
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
AC:
64
AN:
84
Other (OTH)
AF:
AC:
65
AN:
90
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
144
288
432
576
720
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.784 AC: 119337AN: 152234Hom.: 47514 Cov.: 33 AF XY: 0.785 AC XY: 58423AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
119337
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
58423
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
38353
AN:
41560
American (AMR)
AF:
AC:
11123
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2644
AN:
3472
East Asian (EAS)
AF:
AC:
3923
AN:
5172
South Asian (SAS)
AF:
AC:
3097
AN:
4826
European-Finnish (FIN)
AF:
AC:
8509
AN:
10592
Middle Eastern (MID)
AF:
AC:
222
AN:
292
European-Non Finnish (NFE)
AF:
AC:
49084
AN:
68000
Other (OTH)
AF:
AC:
1595
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1265
2531
3796
5062
6327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2441
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.